CMS-2F2-21-001: Emergency Triage, Treat, and Transport (ET3) Model
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Center for Medicare and Medicaid Services notices from 2021.
Center for Medicare and Medicaid Services offered grants of up to $1.2 million to nonprofits, state and local governments, tribes, small businesses and businesses. It expected to make about 40 awards. Applications closed on May 11, 2021.
From the official notice on Grants.gov, last changed March 12, 2021. Checked November 7, 2026.
- Award ceiling$1.2 million
- Expected awards40
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | March 12, 2021 |
|---|---|
| Deadline | May 11, 2021 |
| Archived by Grants.gov | June 10, 2021 |
Who can apply
This opportunity was open to nonprofits, state and local governments, tribes, small businesses and businesses.
All 10 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Native American tribal governments (Federally recognized)
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- For profit organizations other than small businesses
- Small businesses
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Emergency Triage, Treat, and Transport (ET3) model (the “model”) is a voluntary, five-year payment model that will provide greater flexibility to ambulance care teams to address emergency health care needs of Medicare Fee-for-Service (FFS) beneficiaries following a 911 Call. ET3 consists of three interventions: the treatment in place and transport to an alternative destination interventions described in the Request for Applications, and the triage intervention described in this Notice of Funding Opportunity (NOFO). Together, these interventions make up a comprehensive model for potentially improving the quality of care and lowering costs to Medicare by reducing avoidable transports to hospital emergency departments (EDs) and avoidable inpatient admissions. Through the ET3 model NOFO, Centers for Medicare & Medicaid Services (CMS) will fund recipients to establish or expand a Medical Triage Line. Eligible applicants are state and local governments, their Designees, or other entities that operate or have oversight over a Public Safety Answering Point (PSAP). A Medical Triage Line funded through the ET3 model will allow existing PSAPs to redirect Callers with non-emergency conditions to appropriate care alternatives.
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CMS-2F2-21-001 still open?
No. It closed on May 11, 2021.
Who can apply for Emergency Triage, Treat, and Transport (ET3) Model?
Center for Medicare and Medicaid Services accepted applications from nonprofits, state and local governments, tribes, small businesses and businesses.
What is the deadline for Emergency Triage, Treat, and Transport (ET3) Model?
Closed May 11, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.2 million each.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)